J&J wins FDA OK for their nasal spray version of a party drug, now approved for treatment-resistant major depression
There it is.
Despite some serious clinical failures, the FDA has approved J&J’s new drug esketamine for major depression, which will now …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
